Esculentoside A

Esculentoside A can suppress inflammatory responses in LPS-induced ALI through inhibition of the NF-κB and mitogen-activated protein kinase signaling pathways. Esculentoside A may be useful for the treatment of autoimmune disease through modulation on T cell-mediated adaptive immunity. Esculentoside A may play significant roles in the treatment of BXSB mice through modulation of inflammatory cytokines, inhibition of renal cell proliferation and induction of apoptosis.

Product Specifications

CAS Number

65497-07-6

Purity

>98% (HPLC)

Solubility

In Vitro: DMSO : 100 mg/mL (120.92 mM)

Smiles

[C@@H]1 ([C@H] (C[C@]2 ([C@H] ([C@@]1 (CO) C) CC[C@@]1 (C) [C@]3 (C) CC[C@@]4 (C (=O) O) CC[C@] (C) (C (=O) OC) C[C@H]4C3=CC[C@H]21) C) O) O[C@H]1[C@H] (O) [C@@H] (O) [C@H] (O[C@H]2[C@H] (O) [C@@H] (O) [C@H] (O) [C@H] (O2) CO) CO1